Kyverna Therapeutics Statistics
NASDAQ: KYTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
6.18+0.01 (+0.16%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 6.18 0.00%
Kyverna Therapeutics by the numbers
Kyverna Therapeutics has a market capitalization of $382.2 million based on 61.84M shares outstanding. With trailing EPS of $-2.93, Kyverna Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.0% below its 50-day average and 25.8% below its 200-day average.
Average daily trading volume is 898.60K shares, or about $5.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KYTX valuation vs. peer median
| Metric | KYTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $382.19M | $357.34M | +7% |
| Avg. volume | 898.60K | 952.08K | -6% |
Peer median across 8 companies: FENC, ZURA, SCTX, EIKN, CCCC, AGEN, ARTV, OCGN.
Valuation
- Market cap
- $382.19M
- EPS (TTM)
- $-2.93
- Shares outstanding
- 61.84M
Price and trading
- Previous close
- 6.17
- Open
- 6.06
- Day range
- 5.96 – 6.22
- 52-week range
- 5.96 – 13.67
- 52-week change
- +14.05%
- Beta
- —
- Volume
- 1.32M
- Average volume
- 898.60K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 11, 2026
Additional statistics
- Market Cap
- 382.19M
- Forward Pe
- -1.95
- Eps
- -2.93
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 13.67
- Week52 Low
- 5.96
- Avg Volume
- 898.60K
- Shares Outstanding
- 61.84M
- Ma50
- 7.63
- Ma200
- 8.33
- Earnings Date
- Nov 11, 2026
- Pct From52w High
- -54.79%
- Pct From52w Low
- 3.69%